These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 36016154)

  • 21. Evaluation of Clinical Manifestations, Pattern of Involvement, and Surgical Outcomes in Patients with Post Covid-19 Head and Neck Mucormycosis Infection among Patients Admitted To Namazi Hospital, Shiraz, Iran (2021-2022).
    Nahaei M; Motazedian G; Mohammadi AA; Davarpanah MA; Yazdanpanahi P; Ayareh N; Salari F; Keshtkar A
    World J Plast Surg; 2023; 12(3):64-72. PubMed ID: 38226199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conventional PCR as a reliable method for diagnosing invasive mucormycosis in resource-limited settings.
    Pandey M; Xess I; Singh G; Kumar R; Mahapatra M; Jyotsna VP; Agarwal R; Ghosh A; Iram A; Mani P
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 34038342
    [No Abstract]   [Full Text] [Related]  

  • 23. Machine learning based predictive model and systems-level network of host-microbe interactions in post-COVID-19 mucormycosis.
    Verma A; Rathi B
    Microb Pathog; 2022 Jan; 162():105324. PubMed ID: 34861346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucormycosis: The hidden and forgotten disease.
    Darwish RM; AlMasri M; Al-Masri MM
    J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.
    Radotra B; Challa S
    Curr Fungal Infect Rep; 2022; 16(4):206-220. PubMed ID: 36193101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
    Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P
    Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Our 2014 approach to mucormycosis.
    Tacke D; Koehler P; Markiefka B; Cornely OA
    Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Tahiri G; Lax C; Cánovas-Márquez JT; Carrillo-Marín P; Sanchis M; Navarro E; Garre V; Nicolás FE
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review on SARS-CoV-2-associated fungal coinfections.
    Soni S; Namdeo Pudake R; Jain U; Chauhan N
    J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluvastatin: a choice for COVID-19 associated mucormycosis management.
    Tavakkoli A; Johnston TP; Sahebkar A
    Curr Med Chem; 2023 Jul; ():. PubMed ID: 37415368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review.
    Jose A; Singh S; Roychoudhury A; Kholakiya Y; Arya S; Roychoudhury S
    J Maxillofac Oral Surg; 2021 Sep; 20(3):373-380. PubMed ID: 34155426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoinformatic Design of a Multivalent Peptide Vaccine Against Mucormycosis: Targeting FTR1 Protein of Major Causative Fungi.
    Araf Y; Moin AT; Timofeev VI; Faruqui NA; Saiara SA; Ahmed N; Parvez MSA; Rahaman TI; Sarkar B; Ullah MA; Hosen MJ; Zheng C
    Front Immunol; 2022; 13():863234. PubMed ID: 35720422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections.
    Pham D; Howard-Jones AR; Sparks R; Stefani M; Sivalingam V; Halliday CL; Beardsley J; Chen SC
    J Fungi (Basel); 2023 Jun; 9(6):. PubMed ID: 37367595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on mucormycosis pathogenesis.
    Ibrahim AS; Kontoyiannis DP
    Curr Opin Infect Dis; 2013 Dec; 26(6):508-15. PubMed ID: 24126718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis.
    Scherer E; Iriart X; Bellanger AP; Dupont D; Guitard J; Gabriel F; Cassaing S; Charpentier E; Guenounou S; Cornet M; Botterel F; Rocchi S; Berceanu A; Millon L
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29875192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.
    Madhavan Y; Sai KV; Shanmugam DK; Manimaran A; Guruviah K; Mohanta YK; Venugopal DC; Mohanta TK; Sharma N; Muthupandian S
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucor in a Viral Land: A Tale of Two Pathogens.
    Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
    Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fungal Taxa Responsible for Mucormycosis/"Black Fungus" among COVID-19 Patients in India.
    Divakar PK
    J Fungi (Basel); 2021 Aug; 7(8):. PubMed ID: 34436180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.